704 related articles for article (PubMed ID: 30384060)
1. Sodium fluoride induced skeletal muscle changes: Degradation of proteins and signaling mechanism.
Shenoy PS; Sen U; Kapoor S; Ranade AV; Chowdhury CR; Bose B
Environ Pollut; 2019 Jan; 244():534-548. PubMed ID: 30384060
[TBL] [Abstract][Full Text] [Related]
2. High concentration of sodium fluoride in drinking water induce hypertrophy versus atrophy in mouse skeletal muscle via modulation of sarcomeric proteins.
Nagendra AH; Najar MA; Bose B; Shenoy PS
J Hazard Mater; 2022 Jun; 432():128654. PubMed ID: 35286933
[TBL] [Abstract][Full Text] [Related]
3. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.
Enoki Y; Watanabe H; Arake R; Sugimoto R; Imafuku T; Tominaga Y; Ishima Y; Kotani S; Nakajima M; Tanaka M; Matsushita K; Fukagawa M; Otagiri M; Maruyama T
Sci Rep; 2016 Aug; 6():32084. PubMed ID: 27549031
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone Treatment at the Myoblast Stage Enhanced C2C12 Myocyte Differentiation.
Han DS; Yang WS; Kao TW
Int J Med Sci; 2017; 14(5):434-443. PubMed ID: 28539819
[No Abstract] [Full Text] [Related]
5.
Lee MK; Choi YH; Nam TJ
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955507
[TBL] [Abstract][Full Text] [Related]
6. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
[TBL] [Abstract][Full Text] [Related]
7. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
8. A novel in vitro model for the assessment of postnatal myonuclear accretion.
Kneppers A; Verdijk L; de Theije C; Corten M; Gielen E; van Loon L; Schols A; Langen R
Skelet Muscle; 2018 Feb; 8(1):4. PubMed ID: 29444710
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation.
Miki Y; Morioka T; Shioi A; Fujimoto K; Sakura T; Uedono H; Kakutani Y; Ochi A; Mori K; Shoji T; Emoto M; Inaba M
Biochem Biophys Res Commun; 2019 Aug; 516(3):951-956. PubMed ID: 31272716
[TBL] [Abstract][Full Text] [Related]
10. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
11. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
Quinn LS; Anderson BG; Plymate SR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
[TBL] [Abstract][Full Text] [Related]
12. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
13. Effects of type IV collagen on myogenic characteristics of IGF-I gene-engineered myoblasts.
Ito A; Yamamoto M; Ikeda K; Sato M; Kawabe Y; Kamihira M
J Biosci Bioeng; 2015 May; 119(5):596-603. PubMed ID: 25454061
[TBL] [Abstract][Full Text] [Related]
14. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
15.
Eun SY; Chung CH; Cheon YH; Park GD; Lee CH; Kim JY; Lee MS
Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38785149
[TBL] [Abstract][Full Text] [Related]
16. Promotion of myotube differentiation and attenuation of muscle atrophy in murine C2C12 myoblast cells treated with teaghrelin.
Hsieh SK; Lin HY; Chen CJ; Jhuo CF; Liao KY; Chen WY; Tzen JTC
Chem Biol Interact; 2020 Jan; 315():108893. PubMed ID: 31706954
[TBL] [Abstract][Full Text] [Related]
17. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
[TBL] [Abstract][Full Text] [Related]
18. Activation of the β-adrenergic receptor exacerbates lipopolysaccharide-induced wasting of skeletal muscle cells by increasing interleukin-6 production.
Matsukawa S; Kai S; Seo H; Suzuki K; Fukuda K
PLoS One; 2021; 16(5):e0251921. PubMed ID: 34003837
[TBL] [Abstract][Full Text] [Related]
19. [A Cellular Pharmacological Approach to the Development of Drugs to Treat Muscle Wasting].
Sakamoto K
Yakugaku Zasshi; 2018; 138(10):1271-1275. PubMed ID: 30270271
[TBL] [Abstract][Full Text] [Related]
20. Flavones Inhibit LPS-Induced Atrogin-1/MAFbx Expression in Mouse C2C12 Skeletal Myotubes.
Shiota C; Abe T; Kawai N; Ohno A; Teshima-Kondo S; Mori H; Terao J; Tanaka E; Nikawa T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):188-94. PubMed ID: 26052151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
